Filing Details
- Accession Number:
- 0001138723-10-000082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-02 20:23:13
- Reporting Period:
- 2010-08-31
- Filing Date:
- 2010-09-02
- Accepted Time:
- 2010-09-02 20:23:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138723 | Accuray Inc | ARAY | Surgical & Medical Instruments & Apparatus (3841) | 770268932 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1387517 | Chris Raanes | 1310 Chesapeake Terrace Sunnyvale CA 94089 | Svp Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-08-31 | 13,300 | $0.00 | 43,572 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2010-09-01 | 6,000 | $0.75 | 49,572 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-09-01 | 6,000 | $6.18 | 43,572 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2010-09-01 | 6,000 | $0.00 | 6,000 | $0.75 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2010-08-31 | 40,000 | $0.00 | 40,000 | $6.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 260,000 | 2012-12-02 | No | 4 | M | Direct | |
| 40,000 | 2020-08-31 | No | 4 | A | Direct |
Footnotes
- The restricted stock units (RSUs) are released as they vest. A total of 25% of the entire number of shares subject to this RSU grant become vested and are released on the first anniversary of the vesting commencement date and the remaining shares subject to this RSU vest and are released at a rate of 25% a year on each anniversiary of the vesting commencement date over the remaining three years.
- A total of 6,000 shares were sold pursuant to a 10b-5-1 Plan at an average sale price of $6.184817 per share. The actual sale price for the shares was: 1,000 shares at $6.31; 300 shares at $6.12; 280 shares at $6.11; 400 shares at $6.16; 420 shares at $6.13; 1,200 shares at $6.18; 500 shares at $6.15; 100 shares at $6.165; 1,800 shares at $6.17.
- The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.
- These options are exercisable as they vest. The shares subject to this stock option become vested and fully exercisable in equal monthly installments, ratably over a period of 48-months, beginning on October 1, 2010.
Billionaire Hedge Funds
